// App-Quantinova.ai

630 2016 ATVB : Novel Chimeric Anti-proteoglycan Antibody Inhibits Arterial Retention of Proatherogenic Lipoproteins in a Rat Model of Insulin Resistance

Researchers

Presenter

  • Rabban Mangat

Principal Investigators

  • Ana M Vazquez

  • Spencer D Proctor

Medical Centers

  • Univ. of Alberta, Edmonton, Alberta, Canada.

  • Center of Molecular Immunology, La Habana, Cuba

Locations

  • Canada

  • Cuba

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Coronary Artery Disease

  • Diabetes

Biomarkers

  • Insulin

Drug/Treatment

  • Chondroitin sulfate

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim